TyboWe® Adalimumab Injection

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Adult Non-infectious UveitisCrohn's Disease

Phase 4

A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis

RecruitingNCT07663331

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Adult Non-infectious Uveitis

Start: 2026-07-14End: 2028-02-01Target: 30Updated: 2026-07-15

Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®

Not yet recruitingNCT07663526

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Crohn's Disease

Start: 2026-08-01End: 2029-03-01Target: 50Updated: 2026-06-23